GLSHQ (Gelesis Holdings) Other Current Receivables: $8.77 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Gelesis Holdings Other Current Receivables?

Gelesis Holdings GLSHQ -99.00% Other Current Receivables is $8.77 Mil as of Jun. 2023.

Gelesis Holdings's Other Current Receivables for the quarter that ended in Jun. 2023 was $8.77 Mil.

Gelesis Holdings's quarterly Other Current Receivables increased from Dec. 2022 ($7.22 Mil) to Mar. 2023 ($12.84 Mil) but then stayed the same from Mar. 2023 ($12.84 Mil) to Jun. 2023 ($8.77 Mil).

Gelesis Holdings's annual Other Current Receivables increased from . 20 ($0.00 Mil) to Dec. 2021 ($15.60 Mil) but then declined from Dec. 2021 ($15.60 Mil) to Dec. 2022 ($7.22 Mil).

Gelesis Holdings Other Current Receivables Related Terms

Gelesis Holdings Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings Other Current Receivables Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Other Current Receivables
15.60 7.22

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.85 8.68 7.22 12.84 8.77

Gelesis Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $8.77 Mil mean?
Gelesis Holdings (GLSHQ) has a Other Current Receivables of $8.77 Mil as of Jun. 2023. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' Other Current Receivables too high?
Gelesis Holdings' current Other Current Receivables is $8.77 Mil.
How does Gelesis Holdings' Other Current Receivables compare to RBSH and PPCB?
Gelesis Holdings' Other Current Receivables of $8.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current Other Current Receivables is $8.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current Other Current Receivables of $8.77 Mil. The current Other Current Receivables is $8.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current Other Current Receivables is $8.77 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.